AREAS OF EXPERTISE
CMO Selection Process and Contract Negotiation
Supply Chain Creation
Alliance Management
Combination Drug Product Development
Commercialization
CMC
Risk Management
EXPERIENCE
xCell Strategic Consulting – Principal
Dionis Pharma, LLC – Owner
Patheon – Business Development Manager
MicroDose Therapeutx – Associate Director, Solid Oral Dosage Forms
Shionogi Qualicaps, Inc. – Strategic Business Manager
MDS Pharma Services – Associate Director
Ivax – Scientist
Wyeth – Chemist
ASSOCIATIONS
NJ Pharmaceutical Association for Science and Technology
American Association of Pharmaceutical Scientists
NJ Technical Council
Licensing Executives Society
EDUCATION
MS, Industrial Pharmacy, Long Island University
BA, Chemistry, Amherst College
CE, Clinical Development, Mercer County Community College
|
|
Ray Sison, Principal
Ray has over 20 years of achievements managing pharmaceutical drug product development and commercialization efforts. He has extensive experience in program management, outsourced manufacturing, CTM logistics, equipment design/commissioning and facility improvement. His hands-on problem solving approach and strong technical expertise have earned him a reputation as a matrix management leader for fast-paced dynamic organizations. He has real-time experience in the lab and cGMP production floor.
|
Highlights:
-
Established a supply chain for a clinical stage development company to support the commercialization of a 505(b)2 NDA drug/device combination product (dry powder inhaler) that is currently pending FDA approval. The new supply chain operation enhanced the successful out- licensing of the product.
-
Championed development programs for unique dosage delivery systems for virtual and specialty pharmaceutical companies resulting in expanded IP portfolios and more effective commercialized platform technologies including solid oral, liquid, pulmonary and nasal delivery systems.
-
Led sales and marketing efforts for mid-tier and global CDMO/CMOs resulting in strategic partnerships with specialty pharmaceutical companies that drove revenue of $6M to $12M annually.
|